儿童可逆性后部脑病综合征(PRES)临床特征和相关因素分析
Analysis of Clinical Characteristics and Related Factors of Children with Posterior Reversible Encephalopathy Syndrome (PRES)
摘要: 目的:探讨儿童可逆性后部脑病综合征(PRES)临床特征,并进一步分析其相关因素,为临床预防、识别和诊断PRES提供可靠依据。方法:以青岛大学附属医院儿科住院治疗儿童为研究对象,采用1:2配对病例对照研究,利用科研大数据平台调取近8年诊断PRES儿童纳入病例组,同期住院(1年内)、同性别、同科室、年龄 ± 1岁,BMI ± 0.5 kg/m2,未发生可逆性后部脑病患者,纳入对照组。并对病例组进行1年期的随访。结果:近8年共住院患儿220,723例住院儿童中,诊断为PRES共26例,男性18例(66.7%),女性9例(33.3%),发病年龄中位数为11岁(2~16岁)。所有患者均具有神经系统症状,常见的症状包括抽搐(21例,77.8%),头痛11例(42.31%),意识障碍11例(42.31%),视物模糊3例(11.1%),消化道症状3例(11.54%)。其中14例(51.8%)以抽搐为首发临床表现。全身症状发生后72小时内颅脑磁共振特征:多数为双侧对称部位受累,以顶叶、枕叶受累多见,但仍有少数病例出现脑干、延髓病变。大部分病变累及区域出现T1和T2高信号,FLAIR呈高信号或稍高信号、DWI呈等信号或高信号。单因素分析中,病例组中发病前3天出现高血压、肾脏疾病及风湿免疫性疾病、造血干细胞移植相较对照组多见(P < 0.05)。此外病例组中输注血液制品多于对照组(P < 0.05)。血液检查中,镁离子、白蛋白和血红蛋白浓度低于对照组(P < 0.05),钙离子浓度显著低于对照组(P < 0.001)。多因素条件logistic回归分析显示,高血压、低钙为PRES的独立危险因素。结论:儿童PRES均具有神经系统症状,包括抽搐、头痛、意识障碍、视力模糊,少数患者伴有消化系统症状。高血压、肾脏疾病或风湿免疫性疾病、血液制品输注与PRES具有相关性。高血压、低白蛋白血症、低钙血症是PRES的独立危险因素。
Abstract: Objective: To investigate the clinical features of posterior reversible encephalopathy syndrome (PRES) in children, and to further analyze its related factors, to provide a reliable basis for clinical prevention, identification, and diagnosis of PRES. Methods: A 1:2 paired case-control study was used to study children hospitalized in the Department of Pediatrics of the Affiliated Hospital of Qingdao University, and children diagnosed with PRES in the past 8 years were included in the case group by the Scientific Research Big Data Platform, and the patients who were hospitalized (within 1 year), of the same gender, in the same department, aged ±1 year, with a BMI of ±0.5 kg/m2. Patients without PRES were included in the control group. The case group was followed up for 1 year. Results: Among the 220,723 hospitalized children in the past 8 years, 26 were diagnosed with PRES, 18 (66.7%) were males and 9 (33.3%) were females, and the median age of onset was 11 years (2~16 years). All patients had neurological symptoms, including convulsions (21 cases, 77.8%), headache (11 cases, 42.31%), impaired consciousness (11 cases), blurred vision (3 cases, 11.1%), and gastrointestinal symptoms (11.54%). Among them, 14 cases (51.8%) had convulsions as the first clinical manifesta-tion. Brain MRI features within 72 hours after systemic symptoms occurred: most of the patients have bilateral symmetrical site involvement, with parietal and occipital lobe involvement being more common, but there are still a few cases with brainstem and bulbar lesions. T1 and T2 hyper-intensity occurred in most lesions, with high or slightly high intensity in FLAIR and iso- or hyperin-tensity in DWI. In univariate analysis, hypertension, renal disease, rheumatic immune disease, and hematopoietic stem cell transplantation were more common in the case group than in the control group 3 days before the onset of illness (P < 0.05). In addition, the cases of blood products trans-fused are more than the control group (P < 0.05). In the blood tests, the concentrations of magne-sium, albumin and hemoglobin were lower than those of the control group (P < 0.05), and the con-centration of calcium was significantly lower than that of the control group (P < 0.001). Multivariate conditional logistic regression analysis showed that hypertension and hypocalcemia were inde-pendent risk factors for PRES. Conclusion: Children with PRES have neurological symptoms, includ-ing convulsions, headaches, impaired consciousness, blurred vision, and digestive symptoms in a few cases. Hypertension, renal or rheumatological disorders, and blood product transfusions are associated with PRES. Hypertension, hypoalbuminemia, and hypocalcemia are independent risk factors for PRES.
文章引用:刘鑫源, 宋爱琴, 李莉, 吕振梅, 潘华, 刘建科. 儿童可逆性后部脑病综合征(PRES)临床特征和相关因素分析[J]. 临床医学进展, 2023, 13(12): 20563-20571. https://doi.org/10.12677/ACM.2023.13122892

参考文献

[1] Hinchey, J., Chaves, C., Appignani, B., et al. (1996) A Reversible Posterior Leukoencephalopathy Syndrome. The New England Journal of Medicine, 334, 494-500. [Google Scholar] [CrossRef
[2] Li, K., Yang, Y., Guo, D., et al. (2020) Clinical and MRI Features of Posterior Reversible Encephalopathy Syndrome with Atypical Regions: A Descriptive Study with a Large Sample Size. Frontiers in Neurology, 11, Article No. 194. [Google Scholar] [CrossRef] [PubMed]
[3] Granata, G., Greco, A., Iannella, G., et al. (2015) Posterior Reversi-ble Encephalopathy Syndrome—Insight into Pathogenesis, Clinical Variants and Treatment Approaches. Autoimmunity Reviews, 14, 830-836. [Google Scholar] [CrossRef] [PubMed]
[4] Cui, H., Lei, R. and Zhang, B. (2022) Clinical Features and Risk Factors of Mortality in Patients with Posterior Reversible Encephalopathy Syndrome. Behavioural Neurology, 2022, Ar-ticle ID: 9401661. [Google Scholar] [CrossRef] [PubMed]
[5] Legriel, S., Schraub, O., Azoulay, E., et al. (2012) Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome. PLOS ONE, 7, e44534. [Google Scholar] [CrossRef] [PubMed]
[6] Chen, T. (2020) Childhood Posterior Reversible Encephalopathy Syndrome: Clinicoradiological Characteristics, Managements, and Outcome. Frontiers in Pediatrics, 8, Article No. 585. [Google Scholar] [CrossRef] [PubMed]
[7] Ghali, M.G.Z., Davanzo, J., Leo, M., et al. (2019) Posterior Reversi-ble Encephalopathy Syndrome in Pediatric Patients: Pathophysiology, Diagnosis, and Management. Leukemia & Lym-phoma, 60, 2365-2372. [Google Scholar] [CrossRef] [PubMed]
[8] Alhilali, L.M., Reynolds, A.R. and Fakhran, S. (2014) A Multi-Disciplinary Model of Risk Factors for Fatal Outcome in Posterior Reversible Encephalopathy Syndrome. Journal of the Neurological Sciences, 347, 59-65. [Google Scholar] [CrossRef] [PubMed]
[9] Thavamani, A., Umapathi, K.K., Puliyel, M., et al. (2020) Epidemi-ology, Comorbidities, and Outcomes of Posterior Reversible Encephalopathy Syndrome in Children in the United States. Pediatric Neurology, 103, 21-26. [Google Scholar] [CrossRef] [PubMed]
[10] Fischer, M. and Schmutzhard, E. (2017) Posterior Re-versible Encephalopathy Syndrome. Journal of Neurology, 264, 1608-1616. [Google Scholar] [CrossRef] [PubMed]
[11] Raj, S., Overby, P., Erdfarb, A., et al. (2013) Posterior Reversible Encephalopathy Syndrome: Incidence and Associated Factors in a Pediatric Critical Care Population. Pediatric Neurology, 49, 335-339. [Google Scholar] [CrossRef] [PubMed]
[12] Khan, R.B., Sadighi, Z.S., Zabrowski, J., et al. (2016) Imaging Patterns and Outcome of Posterior Reversible Encephalopathy Syndrome during Childhood Cancer Treatment. Pediatric Blood & Cancer, 63, 523-526. [Google Scholar] [CrossRef] [PubMed]
[13] Virojtriratana, T., Hongsawong, N., Wiwattanadittakul, N., et al. (2022) Comparison of Clinical Manifestations, Laboratory, Neuroimaging Findings, and Outcomes in Children with Posterior Reversible Encephalopathy Syndrome (PRES) in Children with and without Renal Disease. Pediatric Neurology, 134, 37-44. [Google Scholar] [CrossRef] [PubMed]
[14] Damrongpipatkul, U., Oranratanachai, K., Kasitanon, N., et al. (2018) Clinical Features, Outcome, and Associated Factors for Posterior Reversible Encephalopathy in Thai Patients with Systemic Lupus Erythematosus: A Case-Control Study. Clinical Rheumatology, 37, 691-702. [Google Scholar] [CrossRef] [PubMed]
[15] Barber, C.E., Leclerc, R., Gladman, D.D., et al. (2011) Posterior Reversible Encephalopathy Syndrome: An Emerging Disease Manifestation in Systemic Lupus Erythematosus. Seminars in Arthritis and Rheumatism, 41, 353-363. [Google Scholar] [CrossRef] [PubMed]
[16] Schmiegelow, K., Attarbaschi, A., Barzilai, S., et al. (2016) Consensus Definitions of 14 Severe Acute Toxic Effects for Childhood Lymphoblastic Leukaemia Treatment: A Delphi Consensus. The Lancet Oncology, 17, e231-e239. [Google Scholar] [CrossRef
[17] Fugate, J.E., Claassen, D.O., Cloft, H.J., et al. (2010) Poste-rior Reversible Encephalopathy Syndrome: Associated Clinical and Radiologic Findings. Mayo Clinic Proceedings, 85, 427-432. [Google Scholar] [CrossRef] [PubMed]
[18] Ishimori, M.L., Pressman, B.D., Wallace, D.J., et al. (2007) Posterior Reversible Encephalopathy Syndrome: Another Manifestation of CNS SLE? Lupus, 16, 436-443. [Google Scholar] [CrossRef] [PubMed]
[19] Fugate, J.E. and Rabinstein, A.A. (2015) Posterior Reversible Encephalopathy Syndrome: Clinical and Radiological Manifestations, Pathophysiology, and Outstanding Questions. The Lancet Neurology, 14, 914-925. [Google Scholar] [CrossRef
[20] Ando, Y., Ono, Y., Sano, A., et al. (2022) Posterior Re-versible Encephalopathy Syndrome: A Review of the Literature. Internal Medicine, 61, 135-141. [Google Scholar] [CrossRef] [PubMed]
[21] Bartynski, W.S. (2008) Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema. American Journal of Neuroradi-ology, 29, 1043-1049. [Google Scholar] [CrossRef
[22] Singhi, P., Subramanian, C., Jain, V., et al. (2002) Reversible Brain Lesions in Childhood Hypertension. Acta Paediatrica, 91, 1005-1007. [Google Scholar] [CrossRef
[23] Forteza, A., Echeverria, Y., Haussen, D.C., et al. (2010) Cerebral Vasomotor Reactivity Monitoring in Posterior Reversible Encephalopathy Syndrome. BMJ Case Reports, 2010, bcr10-bcr2009. [Google Scholar] [CrossRef] [PubMed]
[24] Valdez-López, M., Aguirre-Aguilar, E., Valdés-Ferrer, S.I., et al. (2021) Posterior Reversible Encephalopathy Syndrome: A Neuropsychiatric Manifestation of Systemic Lupus Erythe-matosus. Autoimmunity Reviews, 20, Article ID: 102739. [Google Scholar] [CrossRef] [PubMed]
[25] Bartynski, W.S. and Boardman, J.F. (2008) Catheter Angi-ography, MR Angiography, and MR Perfusion in Posterior Reversible Encephalopathy Syndrome. American Journal of Neuroradiology, 29, 447-455. [Google Scholar] [CrossRef
[26] Potter, T. and Schaefer, T.J. (2023) Hypertensive Encephalopa-thy.
[27] Hu, M.H., Wang, H.S., Lin, K.L., et al. (2008) Clinical Experience of Childhood Hypertensive Encephalopathy over an Eight Year Period. Chang Gung Medical Journal, 31, 153-158.
[28] Amberg, G.C. and Navedo, M.F. (2013) Calcium Dynamics in Vascular Smooth Muscle. Microcirculation, 20, 281-289. [Google Scholar] [CrossRef] [PubMed]
[29] Zamponi, G.W., Striessnig, J., Koschak, A., et al. (2015) The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmaco-logical Reviews, 67, 821-870. [Google Scholar] [CrossRef] [PubMed]
[30] Czosnyka, M., Smielewski, P., Kirkpatrick, P., et al. (1998) Continu-ous Monitoring of Cerebrovascular Pressure-Reactivity in Head Injury. Proceedings of the 10th International ICP Sym-posium, Williamsburg, 25-29 May 1997, 74-77. [Google Scholar] [CrossRef] [PubMed]
[31] Budohoski, K.P., Czosnyka, M., Kirkpatrick, P.J., et al. (2013) Clinical Relevance of Cerebral Autoregulation Following Subarach-noid Haemorrhage. Nature Reviews Neurology, 9, 152-163. [Google Scholar] [CrossRef] [PubMed]